Dahlman Rose & Co. Reiterates Rating, PT On MCP

Dahlman Rose & Co. is reiterating its Buy rating and its $125 price target on Molycorp Inc. MCP in light of the company's recent registration of shares. Says Dahlman Rose, in its report, “Molycorp insiders registered 11.5 million shares, inclusive of the greenshoe, to sell in a secondary offering. This registration may create a slight overhang to the shares climbing higher over the near term, but it does not impact the fundamental valuation over the long term.” MCP close yesterday at $59.03.